Anticoagulant mechanisms

Citations 1-5 of 5 total displayed.

Most recent content (1 May 2003):

Original Contributions
Is Thrombogenesis in Atrial Fibrillation Related to Matrix Metalloproteinase-1 and Its Inhibitor, TIMP-1?

Francisco Marín, Vanessa Roldán, Vicente Climent, Amaya García, Pascual Marco, and Gregory Y.H. Lip
Stroke 34: 1181 -1186; published online before print as doi:10.1161/01.STR.0000065431.76788.D9 [Abstract] [Full text]  

Past content (since Apr 2000):

Articles
Is Thrombogenesis in Atrial Fibrillation Related to Matrix Metalloproteinase-1 and Its Inhibitor, TIMP-1?

Francisco Marín, Vanessa Roldán, Vicente Climent, Amaya García, Pascual Marco, and Gregory Y.H. Lip
Stroke published March 27, 2003, doi:10.1161/01.STR.0000065431.76788.D9 [Abstract]  

Original Contributions
Inhibition of Factor IX(a) Is Protective in a Rat Model of Thromboembolic Stroke

John R. Toomey, Richard E. Valocik, Paul F. Koster, Melanie A. Gabriel, Matt McVey, Timothy K. Hart, Eliot H. Ohlstein, Andrew A. Parsons, and Frank C. Barone
Stroke 2002; 33: 578-585, doi:10.1161/hs0202.102950 [Abstract] [Full text]  

Original Contributions
Atorvastatin Upregulates Type III Nitric Oxide Synthase in Thrombocytes, Decreases Platelet Activation, and Protects From Cerebral Ischemia in Normocholesterolemic Mice • Editorial Comment

Ulrich Laufs, Karen Gertz, Paul Huang, Georg Nickenig, Michael Böhm, Ulrich Dirnagl, Matthias Endres, and Carl J. Vaughan
Stroke 2000; 31: 2442-2449 [Abstract] [Full text]  

Original Contributions
Effects of Fixed Low-Dose Warfarin, Aspirin-Warfarin Combination Therapy, and Dose-Adjusted Warfarin on Thrombogenesis in Chronic Atrial Fibrillation

Foo Leong Li-Saw-Hee, Andrew D. Blann, and Gregory Y. H. Lip
Stroke 2000; 31: 828-833 [Abstract] [Full text]